Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
After projected FDA approval in 2027 to 2028, the MHRA typically follows within 6 to 12 months
Monitoring approaches should be individualized based on risk factors
Moreover, ultrasmall superparamagnetic iron oxide (USPIO) NPs have emerged as diagnostic tools for non-invasive molecular MRI-based evaluation of liver fibrosis [263, 264]
Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical Pharmacology
Trainito A, Muscar C, Gugliandolo A, Chiricosta L, Salamone S, Pollastro F, et al
US$ 23.22
US$ 26.58
US$ 23.18
US$ 20.59
US$ 26.88
US$ 28.88
US$ 26.41
US$ 22.36
